The world of aesthetic medicine continues to evolve—and Daewoong Pharmaceutical, under the visionary leadership of Co-CEOs **Shawn Park** and **Chang-jae Lee**, is proving to be one of its boldest innovators. On November 28, a groundbreaking event unfolded in **Jeddah, Saudi Arabia**: the **Nabota Master Class (NMC) Middle East & North Africa (MENA)**. Held for the first time outside Korea, this two-day gathering attracted over **200 medical professionals** from six major Middle Eastern countries, including Saudi Arabia, the UAE, and Qatar.
Even before this milestone, Nabota was no stranger to the region. It has already expanded into **10 countries in the Middle East**—more markets than any other Korean toxin brand—and continues to see rapid growth in strategic hubs like Saudi Arabia and the UAE. In fact, Saudi Arabia, recognized as the largest aesthetic market in the region, has warmly embraced Nabota thanks to its consistent clinical performance and reputation for safety.
A Master Class in Excellence
The NMC MENA program was more than a conference—it was a vibrant exchange of innovation and expertise. Attendees were treated to sessions led by world-class professionals in aesthetics, anatomy, and plastic surgery, representing both Korea and the Middle East.
From a **facial anatomy lecture** by Professor Seung-Ho Han that sharpened injection safety and precision, to a **protocol-driven training** by Dr. Je-young Park, which showcased specialized techniques like **NABOLIFT** and **NABOGLOW**, the event promoted clinically sound, standardized approaches. The excitement didn’t stop there. Hands-on workshops led by Dr. Jee-soo Kook and other distinguished faculty gave participants a real-world grasp of advanced procedures—bridging science and artistry in aesthetic medicine.
Building a Sustainable Future in Aesthetics
As interest in **botulinum toxin treatments** rises among younger consumers in the Middle East, Daewoong Pharmaceutical has recognized the need for structured **physician education** and strong academic support. By enhancing treatment proficiency, improving patient satisfaction, and fostering collaborative growth, the company envisions a **win–win–win** model that benefits physicians, patients, and the brand alike.
Panel discussions featured prominent Middle Eastern KOLs like Dr. Abdulkader Ramo, Dr. Azzam Alkhalifah, Professor Amir Mrad, and Dr. Carmelo Crisafulli, who shared real-world insights and debated advanced topics such as **dilution methodologies** and **diffusion characteristics**. This in-depth scientific exchange underscored Nabota’s clinical advantages and its unique position in the market.
According to **Jun-soo Yun**, Head of Nabota’s Business Division, NMC MENA was “more than a training event—it was a milestone moment” in establishing new benchmarks for aesthetic medicine in the region. With plans to expand NMC sessions globally—from Asia to Latin America—the future looks bright for Nabota’s role as both an educational platform and a trusted global toxin brand.
By stepping beyond borders and investing deeply in academic collaboration, Daewoong Pharmaceutical is not just selling a product—it’s shaping an ecosystem where medical expertise, patient satisfaction, and innovation intertwine. NMC MENA was proof that knowledge, when shared globally, can elevate aesthetic standards everywhere.
